ArticleCardiovascular research2018

Urocortin 2: will a drug targeting both the vasculature and the right ventricle be the future of pulmonary hypertension therapy?

Kurt R Stenmark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.